María del Carmen
Berasain Lasarte
Catedrática de Universidad
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro de Investigación Médica Aplicada (74)
2024
-
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
Gut
-
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Clinical and Molecular Hepatology, Vol. 30, Núm. 2, pp. 177-190
2023
2022
-
A new animal model of atrophy–hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits
Scientific Reports, Vol. 12, Núm. 1
-
DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis
Cancers, Vol. 14, Núm. 9
-
Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures
Gut, Vol. 71, Núm. 6, pp. 1141-1151
-
SLU7: A New Hub of Gene Expression Regulation—From Epigenetics to Protein Stability in Health and Disease
International Journal of Molecular Sciences, Vol. 23, Núm. 21
2021
-
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma
Hepatology, Vol. 73, Núm. 6, pp. 2380-2396
-
Epigenetic biomarkers for the diagnosis and treatment of liver disease
Cancers, Vol. 13, Núm. 6, pp. 1-15
-
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: Dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis
Gut, Vol. 70, Núm. 2, pp. 388-400
-
Pharoh lncrna regulates myc translation in hepatocellular carcinoma via sequestering tiar
eLife, Vol. 10
-
The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation
Nucleic Acids Research, Vol. 49, Núm. 15, pp. 8592-8609
-
Vitamin A in Nonalcoholic Fatty Liver Disease: A Key Player in an Offside Position?
Cellular and Molecular Gastroenterology and Hepatology
2020
-
Amphiregulin Aggravates Glomerulonephritis via Recruitment and Activation of Myeloid Cells
Journal of the American Society of Nephrology, Vol. 31, Núm. 9, pp. 1996-2012
-
Chromatin dynamics during liver regeneration
Seminars in Cell and Developmental Biology, Vol. 97, pp. 38-46
-
Dual pharmacological targeting of hdacs and pde5 inhibits liver disease progression in a mouse model of biliary inflammation and fibrosis
Cancers, Vol. 12, Núm. 12, pp. 1-27
-
Epigenetic mechanisms in gastric cancer: Potential new therapeutic opportunities
International Journal of Molecular Sciences, Vol. 21, Núm. 15, pp. 1-21
-
Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
Cells, Vol. 9, Núm. 10
-
Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg
JHEP Reports, Vol. 2, Núm. 6
-
Liquid biopsy for cancer management: A revolutionary but still limited new tool for precision medicine
Advances in Laboratory Medicine, Vol. 1, Núm. 3